Alcohol dependence treatment in the EU: A literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland

J. REHM ; M. X. REHM ; H. ALHO ; A. ALLAMANI ; H. J. AUBIN ; G. BÜHRINGER ; J. B. DAEPPEN ; U. FRICK ; A. GUAL ; N. HEATHER | 2013
Dans International Journal of Alcohol and Drug Research (Vol.2, n°2, 2013) Article : Périodique

Aim: To describe guidelines and common practices for alcohol dependence treatment in Europe. Design: Systematic and qualitative review; for each country, guidelines were identified via systematic literature research, followed by interviews with[...]

Plus d'info

Ajouter à la sélection

Lien externe

Brief intervention for male heavy drinkers in routine general practice: a three-year randomized controlled study

M. AALTO ; SEPPÄ K. ; P. MATTILA ; MUSTONEN H. ; RUUTH K. ; HYVÄRINEN H. ; PULKKINEN H. ; H. ALHO ; SILLANAUKEE P. | 2001
Périodique

ENGLISH : The aim of this research was to evaluate the effectiveness of long- term brief intervention in routine general practice. In five primary care out-patient clinics in a Finnish town, 296 male early-phase heavy drinkers consulting a gen[...]

Plus d'info

Ajouter à la sélection

Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients

E. LAUNONEN ; H. ALHO ; E. KOTOVIRTA ; I. WALLACE ; K. SIMOJOKI | 2015
Dans International Journal of Drug Policy (Vol.26, n°9, September 2015) Article : Périodique

Background: Diversion (i.e. selling or giving away) of opioid maintenance treatment (OMT) medications is a challenge that concerns many units providing OMT worldwide and tools for prevention are needed. The object of this study was to examine th[...]

Plus d'info

Ajouter à la sélection

Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls

RAPELI P. ; FABRITIUS C. ; H. ALHO ; SALASPURO M. ; WAHLBECK K. ; KALSKA H. | 2007
Périodique

ENGLISH : BACKGROUND: Both methadone- and buprenorphine-treated opioid-dependent patients frequently show cognitive deficits in attention, working memory, and verbal memory. However, no study has compared these patient groups with each other d[...]

Plus d'info

Ajouter à la sélection

Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern

H. ALHO ; M. DEMATTEIS ; D. LEMBO ; I. MAREMMANI ; C. RONCERO ; L. SOMAINI | 2020
Dans International Journal of Drug Policy (Vol.76, February 2020) Article : Périodique

Use of illicit opioids and misuse of prescription opioids are the main causes of drug-related deaths across the world, and the continuing rise in opioid-related mortality, especially affecting North America, Australia and Europe, is a public hea[...]

Plus d'info

Ajouter à la sélection

Recommandations pour le traitement du trouble de l'usage des opioïdes par la buprénorphine et la méthadone. Consensus européen

M. DEMATTEIS ; M. AURIACOMBE ; O. D'AGNONE ; L. SOMAINI ; N. SZERMAN ; R. LITTLEWOOD ; F. ALAM ; H. ALHO ; A. BENYAMINA ; J. BOBES ; J. P. DAULOUEDE ; C. LEONARDI ; I. MAREMMANI ; M. TORRENS ; S. WALCHER ; M. SOYKA | 2019
Dans Alcoologie et Addictologie (Tome 41, n°4, Décembre 2019) Article : Périodique

FRANÇAIS : Introduction : La prise en charge des patients souffrant d'un trouble de l'usage des opioïdes (TUO) comprend généralement un traitement par agoniste opioïdergique (TAO) dans le cadre d'un plan de traitement intégré. Ces interventions[...]

Plus d'info

Ajouter à la sélection

Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus

M. DEMATTEIS ; M. AURIACOMBE ; O. D'AGNONE ; L. SOMAINI ; N. SZERMAN ; R. LITTLEWOOD ; F. ALAM ; H. ALHO ; A. BENYAMINA ; J. BOBES ; J. P. DAULOUEDE ; C. LEONARDI ; I. MAREMMANI ; M. TORRENS ; S. WALCHER ; M. SOYKA | 2017
Dans Expert Opinion on Pharmacotherapy (Vol.18, n°18, 2017) Article : Périodique

Introduction: Management of patients with opioid use disorder (OUD) commonly includes opioid agonist therapy (OAT) as a part of an integrated treatment plan. These interventions are associated with proven benefits to the individual and society. [...]

Plus d'info

Ajouter à la sélection

Nouveauté

Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs [Commentary]

J. GREBELY ; J. BRUNEAU ; J. V. LAZARUS ; O. DALGARD ; P. BRUGGMANN ; C. TRELOAR ; M. HICKMAN ; M. HELLARD ; T. ROBERTS ; L. CROOKS ; H. MIDGARD ; S. LARNEY ; L. DEGENHARDT ; H. ALHO ; J. BYRNE ; J. F. DILLON ; J. J. FELD ; G. FOSTER ; D. GOLDBERG ; A. R. LLOYD ; J. REIMER ; G. ROBAEYS ; M. TORRENS ; N. WRIGHT ; I. MAREMMANI ; B. L. NORTON ; A. H. LITWIN ; G. J. DORE ; International Network on Hepatitis in Substance Users | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : Périodique

Globally, it is estimated that 71.1 million people have chronic hepatitis C virus (HCV) infection, including an estimated 7.5 million people who have recently injected drugs (PWID). There is an additional large, but unquantified, burden among th[...]

Plus d'info

Ajouter à la sélection

A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone)

SIMOJOKI K. ; H. VORMA ; H. ALHO | 2008
Dans Substance Abuse Treatment, Prevention, and Policy (Vol.3, n°16, 2008) Article : Périodique

BACKGROUND: In Finland, buprenorphine (Subutex) is the most abused opioid. In order to curb this problem, many treatment centres transferred (forced transfer) their buprenorphine patients to the buprenorphine plus naloxone (Suboxone) combination[...]

Plus d'info

Ajouter à la sélection

Lien externe